VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,733,000 | +9.1% | 19,100 | 0.0% | 3.74% | +89.7% |
| Q3 2014 | $2,506,000 | +158.1% | 19,100 | +148.1% | 1.97% | +289.9% |
| Q2 2014 | $971,000 | -52.2% | 7,700 | -50.0% | 0.50% | -53.4% |
| Q1 2014 | $2,030,000 | -62.7% | 15,400 | -66.7% | 1.08% | -63.6% |
| Q4 2013 | $5,436,000 | -57.8% | 46,300 | -62.5% | 2.98% | -58.0% |
| Q3 2013 | $12,895,000 | +21.2% | 123,600 | 0.0% | 7.10% | +25.8% |
| Q2 2013 | $10,639,000 | – | 123,600 | – | 5.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |